Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT).
about
Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant researchAntilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects.Reduced-intensity conditioning for acute myeloid leukemia: is this strategy correct.Management of acute graft-versus-host disease.Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review.Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP.Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia.Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit.Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients.Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies.Massive immune hemolysis after non-myeloablative allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility.Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir.Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus.A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease.Allogeneic hematopoietic cell transplantation for metastatic breast cancer.Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years.Hematopoietic stem cell transplantation for hematological malignancies in Europe.Allogeneic cord blood transplantation for adult acute lymphoblastic leukemia: retrospective survey involving 256 patients in Japan.Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in JapanImpact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors
P2860
Q35031141-8A3B9B4F-E303-48CD-9516-47E3DDD96B9DQ35959473-69CB2400-8A34-45D7-98AF-39A1CF09353FQ36548370-7723B566-D877-4293-82C2-942171F0E2AEQ36773002-F1CEF563-2E7A-49B0-A04F-E3C7C71AC234Q38119863-B09A5B19-B74A-417C-981C-51F535F15FA2Q39049336-C24EC969-0ECE-44CA-838A-798BEEC5BC9BQ39315839-41A3F5EF-5438-400C-863D-BD2965602005Q41896967-64701FC5-55F0-4D81-AB72-AB1A8AB7F671Q43198291-6CDC6694-B71A-4CFB-BC14-8EE84DFEBB42Q43610447-67FA162D-51F3-41A0-8163-8F7D1AB49C6FQ43864374-76D8D063-EF87-4B48-999C-4B8C0DFC6DD9Q44398792-7C5472EA-AD9C-4BFC-9CDE-CF77C7C7081CQ44431125-A628FB18-05D0-4FDA-B07F-9B985E6AD393Q44750611-9483E9F2-52C9-4F6F-BDC5-029E3E62A47EQ44780698-5E06FB30-5529-476A-9016-3F5533956178Q45084811-F2DEE040-EDA8-4FCC-BCF7-5256BFE21138Q46661653-8BE82415-BCCA-4A0E-9268-AF72EFCE5B81Q47908471-D21D3A08-5E6B-4A4D-9DB6-F82C2FA2237EQ53188900-A54521B8-08F1-4BB3-91E6-254F42A395A8Q57917633-23C7C205-EB2A-4C0A-B19F-960832404E1EQ57918913-C11783C4-769D-4C3D-9F39-887FBE881C33
P2860
Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT).
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Second EBMT Workshop on reduce ...... em cell transplants (RI-HSCT).
@ast
Second EBMT Workshop on reduce ...... em cell transplants (RI-HSCT).
@en
Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants
@nl
type
label
Second EBMT Workshop on reduce ...... em cell transplants (RI-HSCT).
@ast
Second EBMT Workshop on reduce ...... em cell transplants (RI-HSCT).
@en
Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants
@nl
prefLabel
Second EBMT Workshop on reduce ...... em cell transplants (RI-HSCT).
@ast
Second EBMT Workshop on reduce ...... em cell transplants (RI-HSCT).
@en
Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants
@nl
P2860
P356
P1476
Second EBMT Workshop on reduce ...... em cell transplants (RI-HSCT).
@en
P2093
Bacigalupo A
P2860
P2888
P304
P356
10.1038/SJ.BMT.1703355
P407
P577
2002-02-01T00:00:00Z
P5875
P6179
1027034231